Investigation of RenovaCare
RenovaCare, Inc. (RCAR) Had Defective Disclosure Controls and Procedures that Caused its Stock Price to be Materially Inflated On May 28, 2021, the SEC issued a release stating it
RenovaCare, Inc. (RCAR) Had Defective Disclosure Controls and Procedures that Caused its Stock Price to be Materially Inflated On May 28, 2021, the SEC issued a release stating it
CorMedix Inc. (CRMD) Failed to Disclose Deficiencies in the Manufacturing Process of its Lead Product Candidate CorMedix completed submission of a New Drug Application (“NDA”) to the U.S. Food and
CarLotz, Inc. (LOTZ, LOTZW) Made False and Misleading Statements Regarding its Busines,s Operations, and Prospects CarLotz became a public entity via merger with Acamar Partners Acquisition Corp., a blank
Full Truck Alliance Co. Ltd. (YMM) Failed to Disclose it was the Subject of a Cybersecurity Review by the Chinese Government that Threatened the Company’s Ability to Operate and Grow
DiDi Global, Inc. (DIDI) Failed to Comply with Privacy Protection Laws The Company sold approximately 316,800,000 shares at $14.00 per share in the IPO, for proceeds of $4,333.1 million.
BlueCity Holdings Limited (BLCT) Misled Investors Regarding the Company’s Capability for Sustainable Growth BlueCity conducted its IPO on July 8, 2020, issuing 5.3 million shares of the Company’s ADSs
Athira Pharma, Inc. (ATHA) Made Misleading Statements Regarding the Research Backing its Drug Candidates On June 17, 2021, Athira issued a press release announcing that the Company’s board of
360 DigiTech, Inc. (QFIN) Made False and Misleading Statements Regarding its Business, Operations, and Prospects During the relevant period, defendants touted the Company’s dedication to privacy protections and data
Ardelyx Inc. (ARDX) Made Misleading Statements in its Registration Statement in Connection with its Initial Public Offering Ardelyx Inc. (ARDX) submitted a New Drug Application (NDA) to the U.S.
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.